When the FDA approved a new pancreatic cancer drug called Rasonque, researchers celebrated. But some patients hoping for quick access have been stymied.
The full data reinforces hopes that the drug could be a breakthrough COPD treatment and reach AstraZeneca's peak annual sales forecast of more than $5 billion.
Brief by WorldPing · Original reporting by CNBC World
An American woman who moved to Paris and soon afterwards was twice diagnosed with breast cancer has spoken to FRANCE 24 about how she managed to get through the trauma.
Brief by WorldPing · Original reporting by France 24